Last reviewed · How we verify
Methemoglobinemia
Approved treatments
- Provayblue
Provayblue works by inhibiting the enzyme amine oxidase [flavin-containing] A, which is involved in the breakdown of certain amines in the body. - Methylthioninium · Shandong Cancer Hospital and Institute
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Methemoglobinemia patent landscape — cliff calendar, originator estates, attackable patents
- Methemoglobinemia treatment landscape brief
- Methemoglobinemia treatment updates RSS
Frequently asked questions about Methemoglobinemia
What drugs treat Methemoglobinemia?
Tracked treatments include Provayblue, Methylthioninium.
What is the treatment for Methemoglobinemia?
Standard treatment for Methemoglobinemia includes Provayblue, Methylthioninium. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Methemoglobinemia patent cliff · Methemoglobinemia CI report
- Treatment: Provayblue
- Treatment: Methylthioninium · Shandong Cancer Hospital and Institute
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing